Bangalore, India, 560085
Empagliflozin 10 mg IR (Immediate Release) is an oral medication used primarily to manage type 2 diabetes mellitus. It belongs to the class of SGLT2 inhibitors (Sodium-Glucose Co-Transporter 2 inhibitors), which work by reducing glucose reabsorption in the kidneys, promoting glucose excretion through urine, and thereby lowering blood sugar levels. This formulation helps improve glycemic control, supports weight management, and may reduce the risk of cardiovascular complications in patients with type 2 diabetes. The IR (Immediate Release) formulation ensures quick absorption, providing rapid therapeutic effects and convenient once-daily dosing. Empagliflozin is often prescribed alongside diet and exercise and may be combined with other antidiabetic medications for optimal blood sugar control.